This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
The writing was on the wall at Sientra. On Nov. 12, the company’s top executives took the fall. The embattled Goleta-based breast implant manufacturer cleaned house Thursday afternoon. Sientra founder and CEO Hani Zeini stepped down as CEO and he will be replaced by industry veteran Jeffrey Nugent. Nicholas Simon also resigned as chairman Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sientra CEO Hani Zeini issued a letter to plastic surgeons Oct. 30 outlining what the Goleta-based breast implant manufacturer needs to do to restart production at its plant in Brazil. Zeini also implied in the letter that the Food and Drug Administration is going to make a decision regarding Sientra products, which is something Read More →
Sientra CEO Hani Zeini said in a conference call on Oct. 28 that he will not speculate about the company’s future. Zeini dodged questions better than a Brooklyn Dodger dodges street cars during the call with investors, analysts and reporters to update all parties about implants contaminated by Sientra’s manufacturer. Sientra shares nosedived on Sept. Read More →
Sientra’s shares nosedived more than 52 percent on Sept. 24 and several law firms around the country announced on Sept. 25 investigations into possible violations of federal securities laws. On Sept. 23, the Goleta-based breast implant manufacturer sold 3 million new shares in a public offering. The offering raised $66 million for the company before Read More →
